Canopy Growth Corp vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.26. The key difference: Canopy Growth Corp is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| CGC | VCIT | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Fixed Income |
52-Week High | $1.92 | $84.82 |
52-Week Low | $0.86 | $81.07 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
VCIT, the Vanguard Intermediate-Term Corporate Bond ETF, trades at $81.295 with a modest 0.28% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The fund maintains competitive advantages with its ultra-low 0.03% expense ratio and approximately 5% yield, holding over 2,000 investment-grade corporate bonds. Recent dividend distributions of $0.33-0.34 highlight its income-focused strategy.
The outlook for VCIT remains favorable for income investors seeking corporate bond exposure with low costs. Key opportunities include the fund's yield advantage over treasury alternatives and consistent monthly distributions. Risks involve interest rate sensitivity and corporate credit quality concerns during economic uncertainty. Wall Street sentiment is generally positive given the fund's cost efficiency and diversification benefits.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →